Form 4: Glaukos Executive Sells Shares Under 10b5-1 Plan

Glaukos Corp. Chief Development Officer Tomas Navratil reported the sale of common stock under a pre-arranged trading plan.

Summary

• Tomas Navratil, Chief Development Officer at Glaukos Corp., sold 716 shares of common stock on July 1, 2026.
• The sale was executed at a price of $139.06 per share.
• This transaction was made under a Rule 10b5-1 trading plan adopted on March 12, 2026.
• Following the sale, Navratil beneficially owns 87,634 shares.
• This total includes 38,817 restricted stock units that are not yet vested.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established 10b5-1 plan, indicating it was planned in advance and not based on recent material non-public information.

Negatives

• Sale of company stock by a key executive.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales, particularly under Rule 10b5-1 plans, are common for executives to diversify holdings or manage personal finances. The context of the sale price relative to the current market price would be a key factor for investors to consider.

Stakeholder Impact

• Shareholders: The sale by an executive may be perceived negatively, but the use of a 10b5-1 plan mitigates concerns about insider trading. The relatively small number of shares sold suggests it may not significantly impact share price.

Key Dates

Keywords

Glaukos Corp, GKOS, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Executive Compensation